Does RUCAPARIB CAMSYLATE Cause Decreased appetite? 787 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 787 reports of Decreased appetite have been filed in association with RUCAPARIB CAMSYLATE (Rubraca). This represents 9.6% of all adverse event reports for RUCAPARIB CAMSYLATE.
787
Reports of Decreased appetite with RUCAPARIB CAMSYLATE
9.6%
of all RUCAPARIB CAMSYLATE reports
17
Deaths
148
Hospitalizations
How Dangerous Is Decreased appetite From RUCAPARIB CAMSYLATE?
Of the 787 reports, 17 (2.2%) resulted in death, 148 (18.8%) required hospitalization.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for RUCAPARIB CAMSYLATE.
What Other Side Effects Does RUCAPARIB CAMSYLATE Cause?
Fatigue (2,494)
Nausea (2,219)
Malignant neoplasm progression (1,162)
Constipation (763)
Diarrhoea (759)
Vomiting (759)
Asthenia (660)
Adverse event (571)
Carbohydrate antigen 125 increased (562)
Dysgeusia (558)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which RUCAPARIB CAMSYLATE Alternatives Have Lower Decreased appetite Risk?
RUCAPARIB CAMSYLATE vs RUFINAMIDE
RUCAPARIB CAMSYLATE vs RUPATADINE
RUCAPARIB CAMSYLATE vs RUXOLITINIB
RUCAPARIB CAMSYLATE vs SABRIL
RUCAPARIB CAMSYLATE vs SACCHAROMYCES CEREVISIAE